Royalty Pharma plc company logo
Royalty Pharma plc logo

Royalty Pharma plc (RPRX) Cash From Operations

Annual CFO

$2.79B$239.06M-7.89%

Summary

Current Value
As of today, RPRX annual cash from operations is $2.79B, down -7.89% on
Historical Performance
RPRX annual cash from operations is up +38.38% over the past 3 years, and up +67.50% over the past 5 years
All-Time High Comparison
RPRX annual cash from operations is currently -7.89% below its historical high of $3.03B set on
3-Year Low Comparison
RPRX annual cash from operations is +30.25% above its 3-year low of $2.14B reached on an earlier date
Sector Comparison
RPRX annual cash from operations is higher than 97.20% of companies in Healthcare sector

Cash From Operations Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

RPRX Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash From Operations$2.79B-7.9%+38.4%+67.5%+113.9%
Quarterly Cash From Operations$703.52M-1.6%+30.6%+38.3%+62.5%
TTM Cash From Operations$2.51B-11.2%+21.5%+27.8%+479.5%
Price$39.72+29.2%+0.9%-23.5%
Annual Cash From Investing-$2.70B-28.1%-47.6%-27.4%-4294.7%
Annual Cash From Financing$356.04M+116.5%+4.4%+129.9%+5377.8%
Annual Free Cash Flow$268.93M-70.7%+255.1%+597.5%-79.4%
Annual CAPEX$2.52B+19.3%+15.2%+46.6%+100.0%
Annual Net Income$1.33B-21.7%+7.2%-45.9%+75.4%

Cash From Operations Highs

RPRX Annual Cash From Operations Highs Comparison
PeriodHighDateCurrent
3Y$3.03B-7.9%
5Y$3.03B-7.9%
All$3.03B-7.9%

Cash From Operations Lows

RPRX Annual Cash From Operations Lows Comparison
PeriodLowDateCurrent
3Y$2.14BN/A+30.3%
5Y$2.02B+38.4%
All$1.31B+113.9%

Cash From Operations History

YearValueChange
$2.79B-7.9%
$3.03B+41.4%
$2.14B+6.2%
$2.02B-1.5%
$2.05B+22.9%
YearValueChange
$1.67B+3.0%
$1.62B+14.1%
$1.42B-4.3%
$1.48B+13.5%
$1.31B-

FAQ

  • What is the current annual cash from operations of RPRX?

    As of today, RPRX annual cash from operations is $2.79B

  • What is 1-year change in RPRX annual cash from operations?

    RPRX annual cash from operations is down -7.89% year-over-year

  • What is 3-year change in RPRX annual cash from operations?

    RPRX annual cash from operations is up +38.38% over the past 3 years

  • How far is RPRX annual cash from operations from its all-time high?

    RPRX annual cash from operations is currently -7.89% below its historical high of $3.03B set on December 31, 2023

  • How does RPRX annual cash from operations rank versus sector peers?

    RPRX annual cash from operations is higher than 97.20% of companies in Healthcare sector

  • When is RPRX next annual earnings release?

    The next annual earnings release for RPRX is on

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In

Data Sources & References

  1. RPRX Official Website www.royaltypharma.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1802768/000180276825000114/0001802768-25-000114-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1802768/000180276825000010/0001802768-25-000010-index.htm
  4. RPRX Profile on Yahoo Finance finance.yahoo.com/quote/RPRX
  5. RPRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rprx